List of Excipients in API lanthanum carbonate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lanthanum carbonate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Takeda Pharmaceuticals America Inc | FOSRENOL | lanthanum carbonate | 54092-252 | DEXTRATES | |
| Takeda Pharmaceuticals America Inc | FOSRENOL | lanthanum carbonate | 54092-252 | MAGNESIUM STEARATE | |
| Takeda Pharmaceuticals America Inc | FOSRENOL | lanthanum carbonate | 54092-252 | SILICON DIOXIDE | |
| Prasco Laboratories | LANTHANUM CARBONATE | lanthanum carbonate | 66993-422 | DEXTRATES | |
| Prasco Laboratories | LANTHANUM CARBONATE | lanthanum carbonate | 66993-422 | MAGNESIUM STEARATE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing lanthanum carbonate
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Teva Pharmaceuticals USA Inc | lanthanum carbonate | 0093-5938 | CROSCARMELLOSE SODIUM |
| Teva Pharmaceuticals USA Inc | lanthanum carbonate | 0093-5938 | DEXTRATES |
| Teva Pharmaceuticals USA Inc | lanthanum carbonate | 0093-5938 | MAGNESIUM STEARATE |
| Teva Pharmaceuticals USA Inc | lanthanum carbonate | 0093-5938 | SILICON DIOXIDE |
| Ascend Laboratories LLC | lanthanum carbonate | 67877-256 | CROSPOVIDONE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for lanthanum carbonate
Excipient focus: CELLULOSE, MICROCRYSTALLINE
lanthanum carbonate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | lanthanum carbonate | 69097-934 |
| Exelan Pharmaceuticals Inc | lanthanum carbonate | 76282-476 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
lanthanum carbonate drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | lanthanum carbonate | 0093-5938 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
lanthanum carbonate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | lanthanum carbonate | 67877-256 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing CROSPOVIDONE
Excipient focus: DEXTRATES
lanthanum carbonate drug variants containing DEXTRATES
lanthanum carbonate drug variants not containing DEXTRATES
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | lanthanum carbonate | 67877-256 |
| >Company | >Ingredient | >NDC |
Excipient focus: GUAR GUM
lanthanum carbonate drug variants containing GUAR GUM
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | lanthanum carbonate | 69097-934 |
| Exelan Pharmaceuticals Inc | lanthanum carbonate | 76282-476 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing GUAR GUM
Excipient focus: HYDROXYPROPYL CELLULOSE
lanthanum carbonate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | lanthanum carbonate | 68180-819 |
| Cipla USA Inc | lanthanum carbonate | 69097-934 |
| Exelan Pharmaceuticals Inc | lanthanum carbonate | 76282-476 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | lanthanum carbonate | 0093-5938 |
| Takeda Pharmaceuticals America Inc | lanthanum carbonate | 54092-252 |
| Prasco Laboratories | lanthanum carbonate | 66993-422 |
| Ascend Laboratories LLC | lanthanum carbonate | 67877-256 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lanthanum carbonate drug variants containing MAGNESIUM STEARATE
lanthanum carbonate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | lanthanum carbonate | 67877-256 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALTITOL
lanthanum carbonate drug variants containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | lanthanum carbonate | 67877-256 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing MALTITOL
Excipient focus: SILICON DIOXIDE
lanthanum carbonate drug variants containing SILICON DIOXIDE
lanthanum carbonate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | lanthanum carbonate | 67877-256 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
lanthanum carbonate drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Ascend Laboratories LLC | lanthanum carbonate | 67877-256 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STEARIC ACID
lanthanum carbonate drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | lanthanum carbonate | 69097-934 |
| Exelan Pharmaceuticals Inc | lanthanum carbonate | 76282-476 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing STEARIC ACID
Excipient focus: SUCRALOSE
lanthanum carbonate drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| Cipla USA Inc | lanthanum carbonate | 69097-934 |
| Exelan Pharmaceuticals Inc | lanthanum carbonate | 76282-476 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing SUCRALOSE
Excipient focus: TALC
lanthanum carbonate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Lupin Pharmaceuticals Inc | lanthanum carbonate | 68180-819 |
| >Company | >Ingredient | >NDC |
lanthanum carbonate drug variants not containing TALC
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch